V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160013860 | 160018902 | 1.73 | 76.8 | Palliative (P) | 2017-11-16 | 2017-11-16 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101519657 |
| 160013863 | 160018903 | 1.76 | 112 | null | 2019-07-21 | 2019-08-11 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 101715121 |
| 160013872 | 160018904 | 1.63 | 69 | Palliative (P) | 2019-07-14 | 2019-07-26 | VINORELBINE | 02 | N | VINORELBINE | 101755754 |
| 160013884 | 160018905 | 1.67 | 93.6 | Palliative (P) | 2017-04-07 | 2018-10-16 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101863464 |
| 160013886 | 160018906 | 1.72 | 88.9 | null | null | null | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101216956 |
| 160013899 | 160018907 | 1.72 | 63.8 | null | 2021-09-25 | 2021-09-29 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100695352 |
| 160013913 | 160018908 | 1.79 | 60.5 | null | null | 2019-06-17 | DOXORUBICIN | 02 | null | DOXORUBICIN | 101348740 |
| 160013914 | 160018909 | 1.68 | 64.75 | null | null | 2020-08-31 | DOXORUBICIN | N | null | NIVOLUMAB | 100485889 |
| 160013917 | 160018910 | 1.68 | 95.15 | Palliative (P) | 2018-03-11 | 2018-03-25 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100696840 |
| 160013918 | 160018911 | 1.63 | 87.3 | Palliative (P) | 2021-06-12 | 2021-07-14 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100311164 |
| 160013933 | 160018912 | 1.73 | 0 | Palliative (P) | 2019-12-24 | 2019-12-27 | DOXORUBICIN | 02 | null | TRIAL UNSPECIFIED | 100821598 |
| 160013935 | 160018913 | null | 106 | Palliative (P) | 2017-08-12 | 2018-01-30 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101632894 |
| 160013944 | 160018914 | 1.56 | 54.9 | Palliative (P) | 2020-06-13 | 2020-07-23 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100224226 |
| 160013951 | 160018915 | 1.84 | 71 | null | 2019-12-05 | 2019-12-20 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101619753 |
| 160013956 | 160018916 | 1.86 | 85.4 | Palliative (P) | 2022-04-04 | 2022-04-04 | DOXORUBICIN | N | N | NIVOLUMAB | 101218897 |
| 160013957 | 160018917 | 1.67 | 75.9 | Palliative (P) | 2018-08-25 | 2018-08-26 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100847128 |
| 160013960 | 160018918 | null | 77 | Palliative (P) | null | 2018-04-02 | Vinorelbine (oral) | 02 | N | VINORELBINE | 101196572 |
| 160013967 | 160018919 | 1.87 | 90.55 | Palliative (P) | 2018-01-10 | 2018-01-10 | Vinorelbine (oral) | 02 | N | VINORELBINE | 100176517 |
| 160013977 | 160018920 | 1.61 | 71 | null | 2017-01-31 | 2017-07-01 | Trial Unspecified | null | null | TRIAL UNSPECIFIED | 100169898 |
| 160014009 | 160018921 | 1.68 | 21.2 | Palliative (P) | null | null | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100228429 |
| 160014019 | 160018922 | 1.6 | 55.55 | Palliative (P) | 2017-02-14 | 2017-05-10 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101111338 |
| 160014021 | 160018923 | 1.72 | 61 | null | 2019-09-20 | 2019-10-02 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100186641 |
| 160014037 | 160018924 | null | 109.8 | Palliative (P) | 2018-06-27 | 2019-06-29 | Bevacizumab | 02 | N | CISPLATIN + PEMETREXED | 100243025 |
| 160014064 | 160018925 | 1.71 | 116 | null | 2018-11-18 | 2018-11-25 | Bevacizumab 7.5mg/kg | 02 | null | DOCETAXEL + GEMCITABINE | 101296044 |
| 160014066 | 160018926 | 1.68 | 76.9 | Palliative (P) | 2020-08-12 | 2020-08-13 | GEMCARBO | 02 | N | CARBOPLATIN + GEMCITABINE | 101246980 |
| 160014087 | 160018927 | 1.69 | 66 | Palliative (P) | 2018-07-15 | 2018-07-17 | Doxorubicin + Olaratumab | 02 | N | DOXORUBICIN + OLARATUMAB | 101088330 |
| 160014097 | 160018928 | 1.67 | 110 | Adjuvant (A) | 2019-05-11 | 2019-05-19 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101371957 |
| 160014133 | 160018929 | 1.74 | 55.7 | Palliative (P) | 2019-02-25 | 2019-02-27 | Paclitaxel (2 or 3 weekly) | N | N | PACLITAXEL | 100503299 |
| 160014138 | 160018930 | 1.74 | 47.6 | Palliative (P) | 2017-01-28 | 2017-01-30 | Bevacizumab 15mg/kg | 02 | N | CARBOPLATIN + PACLITAXEL | 100667969 |
| 160014146 | 160018932 | 1.58 | 69.6 | Palliative (P) | 2021-04-07 | 2021-04-18 | Liposomal Doxorubicin (20mg/m2) | 02 | N | LIPOSOMAL DOXORUBICIN | 101460595 |
| 160014156 | 160018933 | 1.59 | 90.3 | Palliative (P) | 2021-05-20 | 2021-06-02 | DOCETAXEL + GEMCITABINE | 02 | N | DOCETAXEL + GEMCITABINE | 101788832 |
| 160014164 | 160018934 | 1.78 | 60.85 | Adjuvant (A) | 2016-08-16 | 2016-08-30 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100651428 |
| 160014165 | 160018935 | 1.79 | 93.7 | Neo-adjuvant (N) | 2018-07-05 | 2018-07-19 | Liposomal Doxorubicin 40mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 100084199 |
| 160014167 | 160018936 | 1.57 | 68 | Palliative (P) | null | 2021-05-06 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100176565 |
| 160014174 | 160018937 | 1.69 | 56.8 | Palliative (P) | 2016-10-25 | 2016-11-01 | Bevacizumab 15mg/kg | 02 | Y | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101034093 |
| 160014182 | 160018938 | 1.83 | 61.9 | null | 2021-01-30 | 2021-02-06 | GEMCARBO | null | null | CARBOPLATIN + GEMCITABINE | 101144946 |
| 160014201 | 160018940 | 1.7 | 57 | Palliative (P) | 2020-08-01 | 2020-08-10 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + PACLITAXEL | 100414099 |
| 160014217 | 160018941 | 1.69 | 79 | Palliative (P) | 2021-01-27 | 2021-02-10 | Bevacizumab 7.5mg/kg | 02 | 2 | PACLITAXEL | 101109654 |
| 160014240 | 160018942 | 1.89 | 47.6 | null | 2017-06-03 | 2017-06-09 | Bevacizumab 7.5mg/kg | null | null | DOCETAXEL + GEMCITABINE | 101075444 |
| 160014252 | 160018943 | null | 82 | null | 2019-12-02 | 2020-01-16 | Bevacizumab 7.5mg/kg | 02 | null | DOXORUBICIN + OLARATUMAB | 101626147 |
| 160014260 | 160018944 | 1.61 | 82.5 | Palliative (P) | 2021-03-04 | 2021-04-03 | Paclitaxel (2 or 3 weekly) | 02 | Y | PACLITAXEL | 101338387 |
| 160014265 | 160018945 | 1.81 | 79 | Palliative (P) | 2021-01-26 | 2021-01-26 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN | 101288697 |
| 160014271 | 160018946 | 1.73 | 57.6 | Palliative (P) | null | 2019-09-03 | Bevacizumab 7.5mg/kg | 02 | null | CARBOPLATIN + PACLITAXEL | 100692512 |
| 160014272 | 160018947 | 1.76 | 44.9 | Neo-adjuvant (N) | 2019-11-27 | 2020-01-01 | Liposomal Doxorubicin 40mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 100808748 |
| 160014281 | 160018948 | 1.71 | 49 | Neo-adjuvant (N) | 2021-01-19 | 2021-01-22 | Bevacizumab 7.5mg/kg | N | N | BEVACIZUMAB | 100240352 |
| 160014282 | 160018949 | 1.73 | 80 | null | 2017-06-18 | 2017-07-07 | Bevacizumab | 02 | null | CARBOPLATIN | 100985017 |
| 160014283 | 160018950 | 1.5 | 83.6 | Palliative (P) | 2020-02-28 | 2020-03-30 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101271848 |
| 160014286 | 160018951 | 1.7 | 71.3 | Palliative (P) | 2020-10-30 | 2020-11-11 | Liposomal Doxorubicin (Caelyx) | N | N | LIPOSOMAL DOXORUBICIN | 100796367 |
| 160014287 | 160018952 | 1.77 | 68.5 | null | 2019-12-08 | 2019-12-09 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101229864 |
| 160014289 | 160018953 | 1.68 | 83.5 | null | 2017-01-26 | 2017-12-18 | Docetaxel + Gemcitabine (prior RT) | 02 | null | DOCETAXEL + GEMCITABINE | 100788150 |